Related Experiment Video
Updated: May 14, 2026

Biosensor for Detection of Antibiotic Resistant Staphylococcus Bacteria
Published on: May 8, 2013
[Clinical microbiological investigation of vancomycin intermediate Staphylococcus aureus during glycopeptide therapy]
Hirofumi Toda1, Toshihiro Yamaguchi, Takayuki Miyara
1Department of Clinical Laboratory, Kinki University Hospital.
Abstract:
We isolated three strains of vancomycin intermediate Staphylococcus aureus (VISA) from a blood sample of a patient with infective endocarditis (VISA-1), postoperative pneumonia sputum (VISA-2), and pyogenic spondylitis blood sample (VISA-3). These VISA strains did not carry vanA, vanB, vanC1, or vanC2/C3 genes. Cell wall thickening was observed. VISA-1 and VISA-3 PFGE patterns showed the completely same pattern compared to the PFGE pattern of methicillin-resistant Staphylococcus aureus first isolated from patients 1 and 3. After 10 days on brain heart infusion agar, wall thickening in all three type of VISA was unchanged, but VISA-2 and VISA-3 reversed vancomycin susceptibility. The most suitable use of vancomycin in patients with MRSA infection thus appears to be in reducing the opportunity for cell wall thickening.
Insights
Three vancomycin-intermediate Staphylococcus aureus (VISA) strains were identified without common resistance genes. Cell wall thickening was noted, with some strains reversing susceptibility, suggesting vancomycin may help manage MRSA infections by limiting cell wall thickening.
Area of Science:
- Microbiology
- Infectious Diseases
- Antimicrobial Resistance
Background:
- Vancomycin is a critical antibiotic for treating serious Staphylococcus aureus infections, including methicillin-resistant Staphylococcus aureus (MRSA).
- Emergence of vancomycin resistance in Staphylococcus aureus poses a significant threat to public health.
- Understanding the mechanisms and characteristics of vancomycin-intermediate Staphylococcus aureus (VISA) is crucial for effective treatment strategies.
Observation:
- Three distinct VISA strains (VISA-1, VISA-2, VISA-3) were isolated from patients with infective endocarditis, pneumonia, and spondylitis.
- These VISA isolates lacked the vanA, vanB, vanC1, and vanC2/C3 genes, indicating alternative resistance mechanisms.
- Consistent cell wall thickening was observed in all isolated VISA strains.
Findings:
- VISA-1 and VISA-3 exhibited identical pulsed-field gel electrophoresis (PFGE) patterns to the original MRSA strains from the respective patients.
- After prolonged incubation, VISA-2 and VISA-3 demonstrated a reversion of vancomycin susceptibility.
- Cell wall thickening remained consistent in all VISA strains even after extended culture periods.
Implications:
- The study highlights VISA strains with unique genetic profiles and persistent cell wall alterations.
- The observed reversion of susceptibility in some strains suggests dynamic resistance mechanisms.
- Vancomycin's role in managing MRSA infections may involve mitigating cell wall thickening, a key factor in VISA development.
More Related Videos
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Staphylococcal Skin Infections
Inhibitors of Gram-positive Cell Wall Synthesis
Mechanism of Antibiotic Resistance in MRSA
Automated Microbial Diagnostics
Antimicrobial Effectiveness

